HERC2 is an E3 ubiquitin ligase that regulates ubiquitin-dependent degradation of DNA repair proteins including BRCA1, and was an expression outlier in our patient’s tumor, further supporting therapeutic targeting of this pathway which ultimately was not pursued38. This evidence concerns the gene BRCA1 and neoplasm.